Oral and topical sodium cromoglicate in the treatment of diffuse cutaneous mastocytosis in an infant

BMJ Case Reports

Volumn , Issue , 2011, Pages

  Edwards, Alan Martin ^a   Čapková, Štěpánka ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALTODERM; CETIRIZINE; CROMOGLYCATE DISODIUM; DESLORATADINE; DIMETINDENE; KETOTIFEN; LEVOCETIRIZINE; PREDNISONE; TRYPTASE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ARTICLE; BLISTER; BULLOUS SKIN DISEASE; CASE REPORT; CHILD; CONJUNCTIVITIS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIFFUSE CUTANEOUS MASTOCYTOSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; EMULSION; FACE EDEMA; FLUSHING; HUMAN; INFANT; MACULOPAPULAR RASH; MAINTENANCE DRUG DOSE; MALE; PERIPHERAL EDEMA; PRIORITY JOURNAL; SIDE EFFECT; SKIN PRURITUS; SKIN REDNESS; UNSPECIFIED SIDE EFFECT; URTICARIA; URTICARIA PIGMENTOSA; VOMITING;

EID: 79960211070     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.02.2011.3910     Document Type: Article

References (30)

1. Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001;25:603-25. (Pubitemid 32506768)
2. Escribano L, Akin C, Castells M, et al. Mastocytosis: current concepts in diagnosis and treatment. Ann Hematol 2002;81:677-90. (Pubitemid 36104422)
3. Heide R, Beishuizen A, De Groot H, et al. Mastocytosis in children: a protocol for management. Pediatr Dermatol 2008;25:493-500.
4. Cox JS, Beach JE, Blair AM, et al. Disodium cromoglycate (Intal). Adv Drug Res 1970;5:115-96.
5. Pearce FL, Al-Laith M, Bosman L, et al. Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from mast cells from various locations. Drugs 1989;37 ( Suppl 1 ):37-43. (Pubitemid 19170652)
6. Okayama Y, Benyon RC, Rees PH, et al. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin Exp Allergy 1992;22:401-9.
7. Walsh LJ. Ultraviolet B irradiation of skin induces mast cell degranulation and release of tumour necrosis factor-alpha. Immunol Cell Biol 1995;73:226-33.
8. Yang Y, Lu JY, Wu X, et al. G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium. Pharmacology 2010;86:1-5.
9. Dixon M, Jackson DM, Richards IM. The action of sodium cromoglycate on 'C' fibre endings in the dog lung. Br J Pharmacol 1980;70:11-13.
10. Allistone A, Collier JG, Davidson RN, et al. The effect of intravenous sodium cromoglycate on the bronchoconstriction induced by sulphur dioxide inhalation in man. Clin Sci 1985;68:227-32.
11. Vieira Dos Santos R, Magerl M, Martus P, et al. Topical sodium cromoglicate relieves allergen-and histamine-induced dermal pruritus. Br J Dermatol 2010;162:674-6.
12. Vessal G, Sagheb MM, Shilian S, et al. Effect of oral cromolyn sodium on CKD-associated pruritus and serum tryptase level: a double-blind placebo-controlled study. Nephrol Dial Transplant 2010;25:1541-7.
13. Dolovich J, Punthakee ND, MacMillan AB, et al. Systemic mastocytosis: control of lifelong diarrhea by ingested disodium cromoglycate. Can Med Assoc J 1974;111:684-5.
14. Soter NA, Austen KF, Wasserman SI. Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 1979;301:465-9. (Pubitemid 10219950)
15. Czarnetzki BM, Behrendt H. Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate. Br J Dermatol 1981;105:563-7. (Pubitemid 12231499)
16. Frieri M, Alling DW, Metcalfe DD. Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial. Am J Med 1985;78:9-14. (Pubitemid 15159611)
17. Horan RF, Sheffer AL, Austen KF. Cromolyn sodium in the management of systemic mastocytosis. J Allergy Clin Immunol 1990;85:852-5. (Pubitemid 20173119)
18. Sauder DN, Bergfield WF, Krakauer RS. Disodium cromoglycate therapy in mastocytosis. The mast cell - its role in health and disease. Pepys J, Edwards AM, eds. England: Pitman Medical, 1979.
19. Evans S, Vickers CF. Bullous urticaria pigmentosa (cutaneous mastocytosis) and sodium cromoglycate therapy. Acta Derm Venereol 1981;61:572-5. (Pubitemid 12246802)
20. Welch EA, Alper JC, Bogaars H, et al. Treatment of bullous mastocytosis with disodium cromoglycate. J Am Acad Dermatol 1983;9:349-53. (Pubitemid 13051874)
21. Golitz LE, Weston WL, Lane AT. Bullous mastocytosis: diffuse cutaneous mastocytosis with extensive blisters mimicking scalded skin syndrome or erythema multiforme. Pediatr Dermatol 1984;1:288-94. (Pubitemid 14051716)
22. Oranje AP, Soekanto W, Sukardi A, et al. Diffuse cutaneous mastocytosis mimicking staphylococcal scalded-skin syndrome: report of three cases. Pediatr Dermatol 1991;8:147-51.
23. Burger M, Hartmann AA, Wallis S, et al. Bullous cutaneous mastocytosis. Z Hautkr 1991;66:889-91.
24. Cook J, Stith M, Sahn EE. Bullous mastocytosis in an infant associated with the use of a nonprescription cough suppressant. Pediatr Dermatol 1996;13:410-14. (Pubitemid 26326175)
25. Haustein UF, Bedri M. [Bullous mastocytosis in a child]. Hautarzt 1997;48:127-9.
26. Ping-shen F, Meng FU, Wen-ju L, et al. Bullous mastocytosis. J Clin Dermatol 2007;36:26-7.
27. Silva I, Carvalho S, Pinto PL, et al. Mastocytosis: a rare case of anaphylaxis in paediatric age and literature review. Allergol Immunopathol (Madr) 2008;36:154-63.
28. Stainer R, Matthews S, Arshad SH, et al. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial. Br J Dermatol 2005;152:334-41. (Pubitemid 40343607)
29. Edwards AM, Matthews S, Arshad SH. Systemic absorption of sodium cromoglicate from a new cutaneous emulsion (Altoderm) in children with atopic dermatitis. Eur J Dermatol 2010;20:864-5.
30. Briley LD, Phillips CM. Cutaneous mastocytosis: a review focusing on the pediatric population. Clin Pediatr (Phila) 2008;47:757-61.